PO.CL05.04 · 临床研究
Immune Checkpoint Blockade
- 6535 6535 通过PD-L1配体-Ir(III)配合物偶联物增强NSCLC对anti-PD-1-PD-L1治疗的敏感性 Enhancing NSCLC susceptibility to anti-PD-1 - PD-L1 therapy trough PD-L1 ligand-Ir(III) complex conjugates Valentina Pagliara, Giulia Assoni, Giovanna Polcaro, Luigi Liguori, Pierfausto Seneci, Francesco Saverio Di Leva, Vincenzo Maria D’Amore, Cristina R. Ferrone, Stefano Pepe, Luciana Marinelli, Daniela Arosio, Francesco Sabbatino
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
- 6553 6553 HMGB1作为预测小细胞肺癌免疫治疗疗效生物标志物的综合分析 A comprehensive analysis of HMGB1 as a biomarker for predicting immunotherapy efficacy in small cell lung cancer Bohui Zhao, Chaoqi Zhang, Peng Wu, Dongyu Li, Xuanyu Gu, Hengjia Tu, Nan Sun, Jie He
-
-
-
-
-
-
- 6560 6560 靶向适应度监视恢复T细胞免疫并使实体瘤对免疫检查点抑制剂敏感 Targeting fitness surveillance restores T-cell immunity and sensitizes solid tumors to immune checkpoint inhibitors Amit Kumar, Antonio Palma, Praveen Bhoopathi, Esha Madan, Rajan Gogna
-
-
-
-
